A Case of Olfactory Neuroblastoma Developing Bilateral Retropharyngeal Lymph Node Metastasis 14-years After Skull Base Surgery.


Journal

The Kobe journal of medical sciences
ISSN: 1883-0498
Titre abrégé: Kobe J Med Sci
Pays: Japan
ID NLM: 0413531

Informations de publication

Date de publication:
03 Jun 2024
Historique:
medline: 28 6 2024
pubmed: 28 6 2024
entrez: 27 6 2024
Statut: epublish

Résumé

Olfactory neuroblastoma (ONB) is an uncommon malignant tumor and is usually treated by a multidisciplinary approach includes surgery, radiotherapy, and chemotherapy. A 62 years-old male had a tumor in the nasal cavity and diagnosed as ONB with Kadish A stage. Anterior skull base surgery was performed as radical treatment. Since the surgical margin was negative, no postoperative radiotherapy was administered. 14 years after the surgery, bilateral otitis media with effusion (OME) was occurred, we found the recurrence tumor at bilateral retropharyngeal lymph node (RPLN) which surrounded the internal carotid arteries. Since these were unresectable, we planned chemoradiotherapy which was 70Gy of intensity modulated radiotherapy combined with two courses of carboplatin and etoposide. The tumor volume was reduced and bilateral OME were improved. He has been alive for 3 years after salvage treatment. Although ONB has a relatively good prognosis, it is known to often cause cervical lymph node metastasis. Grades III and IV of Hyams classification are considered high risk. This case, initial tumor was limited in the nasal cavity and its clinical classification was early stage, but Hyams classification was grade III. In reference to this case, considering that RPLN metastasis are difficult to radically resect at the salvage surgery, including this area in postoperative radiotherapy was considered an option.

Identifiants

pubmed: 38936878
doi: 10.24546/0100489917
doi:

Types de publication

Journal Article Case Reports

Langues

eng

Sous-ensembles de citation

IM

Pagination

E56-E60

Auteurs

Marie Mizumoto (M)

Department of Otolaryngology-Head and Neck Surgery, Kobe University Hospital, Kobe, Japan.

Tatsuya Furukawa (T)

Department of Otolaryngology-Head and Neck Surgery, Kobe University Hospital, Kobe, Japan.

Mitsuko Yui (M)

Department of Otolaryngology-Head and Neck Surgery, Kobe University Hospital, Kobe, Japan.

Keisuke Iritani (K)

Department of Otolaryngology-Head and Neck Surgery, Kobe University Hospital, Kobe, Japan.

Shun Tatehara (S)

Department of Otolaryngology-Head and Neck Surgery, Kobe University Hospital, Kobe, Japan.

Go Inokuchi (G)

Department of Otolaryngology-Head and Neck Surgery, Kobe University Hospital, Kobe, Japan.

Masanori Teshima (M)

Department of Otolaryngology-Head and Neck Surgery, Kobe University Hospital, Kobe, Japan.

Hirotaka Shinomiya (H)

Department of Otolaryngology-Head and Neck Surgery, Kobe University Hospital, Kobe, Japan.

Hidehito Kimura (H)

Department of Neurosurgery, Kobe University Hospital, Kobe, Japan.

Naomi Kiyota (N)

Cancer Center, Kobe University Hospital, Kobe, Japan.

Ryohei Sasaki (R)

Division of Radiation Oncology, Kobe University Hospital, Kobe, Japan.

Ken-Ichi Nibu (KI)

Department of Otolaryngology-Head and Neck Surgery, Kobe University Hospital, Kobe, Japan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH